Fundz

Medi Print Ophthalmics, Inc. reported raising $2.52 Million in an initial SEC Form D filing, from an offering of $5 Million

PRIVATEMar 17, 2022$2.5M of $5M raised

Amount Raised

$2.52 Million

$2.52 Million sold, per SEC Form D (first sale Mar 17, 2022)

Round Type

Series A

San DiegoHealthcare

Quick answer

MediPrint Ophthalmics, Inc. raised $2.52 Million in a Series A round, dated March 17, 2022. MediPrint Ophthalmics, Inc. is based in San Diego, California, United States.

How much did MediPrint Ophthalmics, Inc. raise?
MediPrint Ophthalmics, Inc. raised $2.52 Million in a Series A round on March 17, 2022.
What does MediPrint Ophthalmics, Inc. do?
MediPrint™ Ophthalmics is an emerging San Diego-based clinical stage eye care pharmaceutical company focused on enhancing vision for life by developing and commercializing a proprietary contact lens based ocular drug..
Where is MediPrint Ophthalmics, Inc. based and how big is it?
MediPrint Ophthalmics, Inc. is based in San Diego, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as MediPrint Ophthalmics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • DENTULU INC raised $3.3M (Seed) on April 29, 2022.
  • Stability Health, LLC raised $7.2M on April 29, 2022.
  • XII Medical, Inc. raised $7.5M on April 29, 2022.
  • StartBox LLC raised $1.7M (Seed) on April 29, 2022.
  • Sunshine Biopharma raised $19M on April 29, 2022.
  • Zetagen Therapeutics raised $9.6M on April 29, 2022.

Who to call at MediPrint Ophthalmics, Inc., and when

A new round usually means MediPrint Ophthalmics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MediPrint Ophthalmics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MediPrint Ophthalmics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MediPrint Ophthalmics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MediPrint Ophthalmics, Inc.

Location

9899 HIBERT STREET

San Diego, California, United States

About

MediPrint™ Ophthalmics is an emerging San Diego-based clinical stage eye care pharmaceutical company focused on enhancing vision for life by developing and commercializing a proprietary contact lens based ocular drug delivery portfolio. There are over 40 million soft contact lens wearers in the United States alone and most of them will develop some eye disease or condition in their lifetime. Treating their disease or condition with eye drops is inconvenient and frustrating, leading millions to become non-compliant or to be forced to drop out of contact lens wear. The Company’s goal is to offer new treatment options that allow millions of patients to continue wearing their contact lens while the lens correcting their vision also delivers drugs to treat their underlying disease or condition. The Company is currently advancing its lead asset, a unique and complete glaucoma treatment, to the clinic while continuing to build out its product portfolio for dry eye and for allergy, and subsequently for other anterior and posterior segment conditions. Approximately 5% of glaucoma patients in the United States wear contact lenses and MediPrint’s innovative drug-eluting, comfort-enhancing, preservative-free contact lens may be an ideal treatment option for them. MediPrint Ophthalmics’ patented MediPrint process offers a unique value proposition for patients, practitioners, strategic partners, and payers. For more information, please visit www.mediprintlens.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MediPrint Ophthalmics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for MediPrint Ophthalmics, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

MediPrint Ophthalmics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.